Jupiter Endovascular closed an oversubscribed $40 million-plus Series B financing to support its transformational ...
Hosted on MSN
Startup offers pricey procedure it says removes microplastics from blood: 'I don't want these things in my body'
A biotech startup has generated buzz around a controversial procedure that the company claims removes microplastics from users' blood, but at a significant price, The Cut recently reported. For around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback